Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
      • Hemcast
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis
      • Cardiovascular Disease
      • Severe Hypertriglyceridemia

    • Coronavirus disease (COVID-19) Resources

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Resources
      • All COVID-19 Updates
      • Vaccine Efforts
      • Antiviral Efforts
      • Partnerships & Anti-Infective Efforts
      • Supporting the Fight Against COVID-19
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Smallpox Vanquished

Smallpox Vanquished
OUR PRODUCTS/ Smallpox Vanquished
April 14, 2017

By GET SCIENCE STAFF - This article originally published on Get Science.

Once one of the world’s deadliest diseases, smallpox’s complete eradication was the result of a worldwide deployment of a vaccine begun 50 years ago. To date it’s still the only human disease ever to disappear from Earth.

Considered one of the greatest achievements of the 20th century, alongside the likes of getting a man on the moon, and one of the greatest medical feats in all of human history, smallpox was officially declared eradicated from the planet in 1980.

The big push for its eradication began 50 years ago, in 1967. The disease’s story started a lot earlier.

A Brief History of A Killer

Called the “red plague” or the “speckled monster,” smallpox is a virus that killed almost a third of its victims. Characterized by pus-filled sores on the skin, its symptoms include pneumonia, brain inflammation, blindness from corneal ulcerations, and disfiguring pockmarks.

Thought to have begun as a rodent virus circa 10,000 B.C., it would subsequently spread to humans and ravage whole populations. A large-scale epidemic is thought to have spurred the decline of the Roman Empire. Conquistadores from Spain and Portugal brought it to the New World, where it took down the Inca and Aztec empires. It killed 80 percent of the Native Americans who caught it from settlers. In 18th century Europe, 400,000 died annually of smallpox.

The disease didn’t discriminate. George Washington, Andrew Jackson, and Abraham Lincoln were all survivors. Egyptian Pharaoh Ramses V had smallpox scars on his mummy.

Mobilizing a Cure

Necessity spurred ingenuity. The smallpox vaccine, developed in England by Edward Jenner in 1796, was the modern world’s first successful vaccine (and became the precursor to the vaccine used for eradication). Jenner’s idea was to inject healthy individuals with just a little bit of a less deadly, but closely related, disease called cowpox. The word vaccination is from the Latin for cow, vacca.


By 1949, due to a blanketing of vaccinations, the U.S. was declared smallpox free. In the mid-1950s, Russia in particular was clamoring for a global push to follow suit and rid the whole Earth of the disease. A first global wave of vaccinations began in 1958. By the 1960s, smallpox was confined to Brazil, West-Central Africa, East-Southern Africa, the Indian subcontinent, and Indonesia.

Smallpox, eliminated in much of the West after World War II, persisted in Brazil, Africa, and South Asia. In 1944, India had the highest incidence of any country on record in the 20th century: more than 300,000 cases. The rise of immigration, trade, and leisure travel kept smallpox circulating through most of the 20th century.

The vaccination process itself got a whole lot better in the mid-1960s with the introduction of a bifurcated prong that scraped the skin so that the vaccine didn’t need injecting. In addition, freeze-drying made the vaccine temperature stable for tropical distribution.


In 1967, the World Health Organization launched a full-force global eradication program, an effort led by Dr. Donald A. Henderson. During the year that this intensified program began, there were an estimated 10–15 million cases of smallpox across 31 countries.  Through a concerted effort of armies of volunteers spread across every inhabited corner of the planet, by 1967, 80 percent of the population of each country of the world was vaccinated.

But smallpox’s real death knell came from a Hail-Mary idea from one of Henderson’s team, American epidemiologist William H. Foege. When running low on vaccine during a 1967 Nigerian outbreak, Foege had the idea of vaccinating in rings around cases, starting with family and all recent contacts. Then they’d vaccinate everyone who had contacts with those contacts. This soon became the go-to vaccination plan globally.

In 1967, as part of a global eradication effort, workers vaccinated 25 million people.

Death Knell of a Deadly Disease


In October, 1977, Ali Maow Maalin, a hospital cook in Somalia, had the distinction of becoming the last person in the world to contract smallpox naturally. By 1980, smallpox was declared officially eradicated.

“Vaccines are the single most important instrument to protect public health,” says Bill Gruber, head of vaccine clinical research and development at Pfizer. “Smallpox is a disease that used to kill many people throughout the world. [Estimates state that it killed 300 million in the 20th century alone.] It no longer exists.”

Eradication didn’t stop in 1980 though. Stockpiles of millions of doses of smallpox still exist around the world. In the U.S., there are currently enough supplies to vaccinate every single citizen in case of emergency.

Many soldiers being deployed still get the vaccine. Thanks to the efforts of Dr. Henderson and his team, the general population doesn’t need to.
—Johnna Rizzo


Map Source: World Health Organization, “Smallpox and its Eradication.” All country borders shown are modern; incidences shown reflect cases as they occurred in historic boundaries.

Related Hot Topics
BIOs_picture2_380x300.jpg
Pfizer Pearl River site focusing on next generation of vaccines
world_data300x170.jpg
Collection and Use of Real-World Data Continues to Grow Around the World
pearl_river300x170.jpg
Pearl River legacy of innovation
Cancer as a ‘Catalyst’: Helping Patients With Cancer Live Their Lives
Cancer as a ‘Catalyst’: Helping Patients With Cancer Live Their Lives
Introducing SpringWorks Therapeutics
Introducing SpringWorks Therapeutics
A New Frontier for AI: Helping Scientists Develop Potential New Medicines
A New Frontier for AI: Helping Scientists Develop Potential New Medicines
Media Name: CDK_Image_Thumbnail 1_300x170.png
Pfizer Builds on Nobel Prize-Winning Research to Fight Cancer
Media Name: wonderbag_1000x450px.jpg
Pfizer Vaccines - Wonderbag Collaboration
Tags
Scientific Innovation
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.